Clinical Trial Update: In Hepatitis C Patients Treated With Interferon and Ribavirin, Does Hepcidin Contribute to Treatment Induced Anaemia

View source ↗

Summary

A completed clinical study investigates whether hepcidin contributes to treatment-induced anaemia in hepatitis C patients treated with interferon and ribavirin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Interferon Alfa (interferon alfa)
• Ribavirin (ribavirin)

Snippet

Sponsor: Fremantle Hospital and Health Service | Conditions: Hepatitis C | Status: COMPLETED